Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Salivary Gland Neoplasms 1Recurrence 1Neoplasms 1Neoplasm Metastasis 1Leukemia, Myeloid, Acute 1Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1

Interventions

selinexor 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Extensive Stage Small Cell Lung Cancer (ES-SCLC) × selinexor × Clear all
NCT06853678 2025-03-03

Second-line Immunotherapy for ES-SCLC

Tianjin Medical University Cancer Institute and Hospital

Phase NA Recruiting
30 enrolled
Thoracic

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡